Rheumatology Network Features Special Coverage on Lupus for Lupus Awareness Month

May 20, 2014

NORWALK, Conn., May 20, 2014 /PRNewswire/ — UBM Medica US announces that Rheumatology Network, a leading online community for Rheumatologists, offers special content for rheumatologists in honor of Lupus Awareness Month.

Lupus, a chronic disease in which a person’s immune system mysteriously attacks many parts of her own body (most affected people are women of childbearing age), most commonly the skin, joints, and organs. In its more severe forms it can attack the kidneys, causing lupus nephritis. According to the Lupus Foundation of America, an estimated 1.5 million Americans have lupus, and more than 16,000 new cases are diagnosed each year.

The rheumatologists who read Rheumatology Network are the front-line doctors for treatment of lupus, and this month the online publication offers numerous important new features on the topic:

    --  The latest edition of the weekly RN Practice Poll, which surveys readers
        about how they approach the management of unresolved issues in
        rheumatology, inquires how they treat lupus nephritis.
    --  A quiz by an expert on the topic helps readers test their skills in
        diagnosis of catastrophic antiphospholipid syndrome (CAPS), a rare but
        devastating condition most common among lupus patients, which causes
        blood clots to form rapidly in numerous different sites within the body.
    --  Experts from Harvard Medical School describe their new research that
        defines an important predictor of serious infections in lupus patients,
        a major cause of illness and hospitalization among these women.
    --  A report describes new recommendations from an international panel about
        how best to treat lupus in order to achieve remission, complete control
        of symptoms.

About UBM Medica US

Addressing today’s healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach — online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Connect brings together UBM’s healthcare business, UBM Medica US; UBM Canon’s advanced design and manufacturing event, online and print brands; UBM Connect New York’s catering, cruise shipping, customer management, and fine, specialty and custom chemical communities; and UBM Mexico’s concrete show. For more information, visit www.UBMMedicaUS.com.

About UBM plc

UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world’s buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.

For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.

Media contact:

Jason J. Golden

Content Marketing Manager




Source: PR Newswire

comments powered by Disqus